Symbols / OMGA
OMGA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-11-14 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $0.14 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-15 | main | Piper Sandler | Overweight → Overweight | $4 |
| 2024-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $12 |
| 2024-08-07 | reit | Wedbush | Outperform → Outperform | $12 |
| 2024-08-07 | main | Chardan Capital | Buy → Buy | $6 |
| 2024-06-18 | init | Raymond James | — → Outperform | $12 |
| 2024-05-13 | reit | HC Wainwright & Co. | Buy → Buy | $12 |
| 2024-05-07 | main | Chardan Capital | Buy → Buy | $7 |
| 2024-04-30 | reit | HC Wainwright & Co. | Buy → Buy | $12 |
| 2024-04-03 | reit | Piper Sandler | Overweight → Overweight | $9 |
| 2024-04-01 | main | Chardan Capital | Buy → Buy | $7 |
| 2024-01-04 | reit | Wedbush | Outperform → Outperform | $12 |
| 2023-11-13 | main | HC Wainwright & Co. | Buy → Buy | $12 |
| 2023-11-10 | main | Wedbush | Outperform → Outperform | $12 |
| 2023-09-01 | reit | HC Wainwright & Co. | Buy → Buy | $11 |
| 2023-08-04 | reit | Chardan Capital | Buy → Buy | $12 |
| 2023-06-06 | reit | HC Wainwright & Co. | Buy → Buy | $11 |
| 2023-05-08 | reit | Chardan Capital | — → Buy | $12 |
| 2023-03-31 | reit | HC Wainwright & Co. | — → Buy | $11 |
| 2023-03-24 | reit | HC Wainwright & Co. | — → Buy | $11 |
| 2023-03-10 | init | JonesTrading | — → Buy | $11 |
- Flagship-backed Omega signals it’s headed toward bankruptcy - BioPharma Dive ue, 04 Feb 2025 08
- If You Invested $1,000 In Omega Healthcare Stock 20 Years Ago, How Much Would You Have Now? - Yahoo Finance hu, 19 Sep 2024 07
- Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship - BioSpace ue, 04 Feb 2025 08
- Omega Therapeutics to sell assets amid Nasdaq delisting - Investing.com Mon, 24 Feb 2025 08
- Shares of Flagship-founded biotech fall as CEO departs - The Business Journals Fri, 15 Nov 2024 08
- Omega Therapeutics Announces Pricing of Initial Public Offering - PR Newswire hu, 29 Jul 2021 07
- Case Summary: Omega Therapeutics Chapter 11 - Bondoro Wed, 12 Feb 2025 08
- Omega Therapeutics Faces Leadership Change and Takeover Proposal - Yahoo Finance Wed, 01 Jan 2025 08
- Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy' (NASDAQ:OMGA) - Seeking Alpha Sun, 31 Mar 2024 07
- Modified Disclosure Statement and Liquidation Plan Approved on an Interim Basis for Omega Therapeutics, Inc. - marketscreener.com Fri, 13 Jun 2025 07
- Novo Nordisk Stock Hit a Record on Thursday. Here's Why. - Investopedia hu, 04 Jan 2024 08
- Why Is Sellas Life Sciences (SLS) Stock Down 25% Today? - InvestorPlace hu, 04 Jan 2024 08
- Omega Therapeutics enters restructuring agreement - Investing.com Mon, 03 Feb 2025 08
- Omega Pacific Resources Earns 51% Interest in Williams Property - Junior Mining Network ue, 12 Nov 2024 08
- We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully - Yahoo Finance Fri, 29 Mar 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for OMGA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|